Prognostic value of baseline serum HER2 extracellular domain level with a cut-off value of 15 ng/mL in patients with breast cancer: a systematic review and meta-analysis.
Zhuo ZhangChao LiHongwei FanQian XiangLing XuQianxin LiuShuang ZhouQiufen XieShuqing ChenGuangyan MuYi Min CuiPublished in: Breast cancer research and treatment (2018)
An elevated sHER2 ECD level with a cut-off value of 15 ng/mL was associated with poor clinical prognosis in patients with BC. Future studies should be conducted to reduce confounding and explore the mechanism.
Keyphrases